Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Passes US OTC Monograph Reform And Committee Clears HSA Change

Executive Summary

Next step for OTC monograph reform legislation is Senate consideration; market exclusivity periods are likely focus of House/Senate conference. Separate bill to allow consumers to use health savings accounts to buy OTC drugs without a doctor's prescription clears House Ways and Means panel.

Advertisement

Related Content

House Maintains Momentum For US OTC Monograph Reform, But Senate Remains A Question Mark
US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators
US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators
OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns
Direct OTC Purchases With Pre-Tax Accounts Swing On ACA Change, Not Repeal
Direct OTC Purchases With Pre-Tax Savings Accounts Passes House

Topics

Advertisement
UsernamePublicRestriction

Register

PS123518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel